Jindong Xie
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
-
- Ferroptosis and cancer prognosis 12
- Molecular Biology top 10%
- RNA modifications and cancer 15
- Single-cell and spatial transcriptomics 5
- Circular RNAs in diseases 5
- Immunology top 10%
- Immune cells in cancer 7
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (3 papers)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jindong Xie
52 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 641
- Oncology 576
- Pulmonary and Respiratory Medicine 576
- Molecular Biology 1.1k
- Immunology 311
Countries citing papers authored by Jindong Xie
This map shows the geographic impact of Jindong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jindong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jindong Xie more than expected).
Fields of papers citing papers by Jindong Xie
This network shows the impact of papers produced by Jindong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jindong Xie. The network helps show where Jindong Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jindong Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 6 | |
| 4 | Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironmentbreakdown → | 2025 | 20 |
| 5 | 2025 | 2 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 35 | |
| 8 | 2024 | 23 | |
| 9 | 2024 | 28 | |
| 10 | 2024 | 44 | |
| 11 | 2024 | 21 | |
| 12 | Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategiesbreakdown → | 2024 | 50 |
| 13 | 2024 | 42 | |
| 14 | 2023 | 17 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 70 | |
| 17 | The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancerbreakdown → | 2022 | 191 |
| 18 | N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancerbreakdown → | 2022 | 167 |
| 19 | 2022 | 16 | |
| 20 | 2022 | 28 |
About Jindong Xie
Jindong Xie is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Ferroptosis and cancer prognosis (12 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (7 papers), Cancer-related molecular mechanisms research (6 papers), Single-cell and spatial transcriptomics (5 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (641 citations), Oncology (576 citations) and Pulmonary and Respiratory Medicine (576 citations). Jindong Xie has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yutian Zou, Xinpei Deng, Yuhui Tang, Hailin Tang, W. H. Tian, Xiaoming Xie, Shaoquan Zheng, Linyu Wu, Chau‐Wei Wong and Xueqi Ou. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.